Progressive Care, Inc.

$2.11+5.50%(+$0.11)
TickerSpark Score
55/100
Mixed
84
Valuation
30
Profitability
50
Growth
60
Health
50
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RXMD research report →

52-Week Range42% of range
Low $0.40
Current $2.11
High $4.50

Companyprogressivecareus.com

Progressive Care, Inc. , through its subsidiary, Pharmco, LLC, provides prescription pharmaceuticals to individuals and institutions in south Florida. The company operates a retail pharmacy that specializes in the sale of anti-retroviral medications and related patient care management; the sale and rental of durable medical equipment (DME), such as hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories; and the supply of various prescription medications to long term care facilities.

CEO
Charles M. Fernandez
IPO
2010
Employees
143
HQ
Hallandale Beach, FL, US

Price Chart

-61.36% · this period
$5.46$3.42$1.38Sep 14Mar 15Sep 30

Valuation

Market Cap
$13.49M
P/E
-0.89
P/S
0.27
P/B
0.49
EV/EBITDA
5.04
Div Yield
0.00%

Profitability

Gross Margin
30.49%
Op Margin
-0.25%
Net Margin
-29.46%
ROE
-85.71%
ROIC
-0.33%

Growth & Income

Revenue
$49.73M · 22.47%
Net Income
$-14,648,000 · -148.11%
EPS
$-2.36 · -16.26%
Op Income
$-124,000
FCF YoY
-78.46%

Performance & Tape

52W High
$4.50
52W Low
$0.40
50D MA
$1.77
200D MA
$2.21
Beta
-0.21
Avg Volume
1.86K

Get TickerSpark's AI analysis on RXMD

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Oct 9, 23RODRIGUEZ PEDROother11,111
Apr 18, 23RODRIGUEZ PEDROother15,000
Oct 7, 22RODRIGUEZ PEDROother0
Jul 1, 23Barreto Rodneyother230,000
Jul 1, 23Barreto Rodneyother340,599
Jul 1, 23Barreto Rodneyother455,000
Jul 1, 23Barreto Rodneysell168,386
Jul 1, 23Barreto Rodneysell224,944
Jul 1, 23Barreto Rodneyother228,240
Jul 1, 23Barreto Rodneyother30,000

Our RXMD Coverage

We haven't published any research on RXMD yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate RXMD Report →

Similar Companies